Abstract
Get full access to this article
View all access options for this article.
References
1.World Health Organization. Global polio eradication initiative strategic plan 2004-2008. Wkly Epidemiol Rec 2004 ; 79 : 55 –7
2.
Patriarca
PA
,
Wright
PF
,
John
TJ
. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991 ; 13 : 926 –39
3.
Sutter
RW
,
Cochi
SL
,
Melnick
JL
. Live attenuated poliovirus vaccines. In:
Plotkin
S
,
Oreinstein
W
, eds. Vaccines. 3rd edn. Philadelphia : Saunders , 1999 : 364 –408
4.
Sutter
RW
,
Patriarca
PA
,
Suleiman
AJ
, Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol 1993 ; 22 : 936 –44
5.
Orenstein
WA
,
Bernier
RH
,
Dondero
TJ
, Field evaluation of vaccine efficacy. Bull World Health Organ 1985 ; 63 : 1055 –68